Table 3.
Represented results for outcome evolution are those from groups treated with MT. In the case of pain not being measured with VAS, it will be referenced by using a percentage (0–100).
| Author | Outcomes (Main; Secondary) |
Follow-Up | Outcome Evolution | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pain (VAS) | MMO (mm) | |||||||||||
| Base | Post | 3 M | 6 M | 1 Y | Base | Post | 3 M | 6 M | 1 Y | |||
| Garrigós-Pedrón M. (2018) |
CF-PDI, HIT-6; TSK-11, VAS, temporal; masseter muscle and wrist PPT; pain-free active MMO | 6 weeks 3 months |
7.63 (1.16) | 5.965 (1.426) ** d = 1.31 |
4.126 (2.150) ** d = 2.75 |
− | − | 32.87 (7.16) | 37.22 (5.98) ** d = −0.61 |
41.13 (6.49) ** d = −1.15 |
− | − |
| Nagata K. (2018) |
Active MMO, pain and noises from TMJ using NRS 0–10 | Every 2 weeks, for 18 weeks | 5.76 (2.26) | GRAF | GRAF | − | − | 28.32 (4.55) | GRAF | GRAF | − | − |
| Craane B. (2012) |
MPQ, VAS, MFIQ, active and passive MMO (mm), masseter and temporal muscle PPT | 3, 6, 12, 26, 52 weeks | 5.0 (3.8–6.0) |
− | 2.3 (0.65–3.35) | 1.75 (0.05–3) | 0.2 (0–1.6) |
35.8 (7.4) | − | 39.4 (6.3) | 41.6 (6) | 42.7 (5.7) |
| Guarda-Nardini L. (2011) |
VAS, ROM | 3 months | 6.0 (2.0) | 2.1 (1.4) * |
2.5 (2.2) * |
− | − | 52.0 (9.5) | − | 52.4 (N.S.) |
− | − |
| Kalamir A. (2011) |
0–11 scale for pain at rest, MMO, plus both of them while clenching their jaws; MMO (mm), GRC 0–7 | 6 weeks 6 months 1 year |
4.46 (6.41) = 4.05(5.82) 4.26 (7.49) = 3.87(6.81) |
− | − (N.S.) | GRAF | −3.1 = −2.82 −4.0 = −3.6 |
37.42 39.89 |
− | − | GRAF | GRAF |
| Ismail F. (2007) |
Active and passive MMO (mm), protrusion movement (mm), VAS (total, during movement, at rest, after mandibular loading) | 1 week 1 month 6 weeks 3 months |
4.5 (2) | − | −2.8 (2.1) | − | − | 30.1 (5.4) | − | 40.8 (4.1) | − | − |
CF-PDI: Cranio-Facial Pain and Disability Inventory; HIT-6: Headache Impact Test; TSK-11: Tampa Scale for Kinesiophobia; PPT: Pain Pressure Threshold; MMO: Maximal Mouth Opening; NRS: Numeric Rating Scale; MPQ: McGuil Pain Questionnaire; MFIQ: Migraine Functional Impact Questionnaire; GRC: Global Reporting of Change; N.S.: Non-significant results; *: p< 0.05; **: p< 0.001; GRAF: Results from the original document were shown in graphical form only, resulting in an inability to quantify them accurately.; ROM: range of motion; VAS: visual analogue scale.